170 related articles for article (PubMed ID: 19088693)
1. MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma.
Boubaker A; Bischof Delaloye A
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):388-402. PubMed ID: 19088693
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
Boubaker A; Bischof Delaloye A
Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
[TBL] [Abstract][Full Text] [Related]
4. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
[TBL] [Abstract][Full Text] [Related]
6. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
[TBL] [Abstract][Full Text] [Related]
7. [Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Hammami H; Hassine L; Mhiri A; Sellem A; Oubich F; Gharssallah L; Barsaoui S; Ben Brahim H
Tunis Med; 2007 May; 85(5):413-6. PubMed ID: 17657930
[TBL] [Abstract][Full Text] [Related]
8. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
[TBL] [Abstract][Full Text] [Related]
9. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
[TBL] [Abstract][Full Text] [Related]
11. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
12. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Schwarz KB; Driver I; Lewis IJ; Taylor RE
Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
Schmidt M; Simon T; Hero B; Schicha H; Berthold F
Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
[TBL] [Abstract][Full Text] [Related]
14. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
Kraal KC; Bleeker GM; van Eck-Smit BL; van Eijkelenburg NK; Berthold F; van Noesel MM; Caron HN; Tytgat GA
Eur J Cancer; 2017 May; 76():188-196. PubMed ID: 28329731
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
16. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
17. [Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy].
Benz-Bohm G; Gross-Fengels W; Widemann B; Linden A
Rofo; 1990 May; 152(5):523-7. PubMed ID: 2160683
[TBL] [Abstract][Full Text] [Related]
18. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
Hausegger KA; Fueger GF; Ebner F; Urban C
Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
[TBL] [Abstract][Full Text] [Related]
19. Role of iodine-131 MIBG scanning in the management of paediatric patients with neuroblastoma.
Shah Syed GM; Naseer H; Usmani GN; Cheema MA
Med Princ Pract; 2004; 13(4):196-200. PubMed ID: 15181323
[TBL] [Abstract][Full Text] [Related]
20. Pediatrics: diagnosis of neuroblastoma.
Sharp SE; Gelfand MJ; Shulkin BL
Semin Nucl Med; 2011 Sep; 41(5):345-53. PubMed ID: 21803184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
